National Standar (504882)

FairStock Score: 14/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 6/9 suggests moderate short-term financial health.
• Profit growth of 51.16% shows some earnings recovery, albeit from a small base.
• Latest quarter is profitable at ₹3 crore net profit, not a loss-making situation.
• ROCE and ROE are both positive, indicating the company is not burning cash at the operating level.

Concerns

• Extreme valuation: P/E of 225.81 and P/B of 33.26 against book value of just ₹138.98.
• Sales collapsed by 79.80%, and latest quarterly sales of ₹3 crore are minuscule relative to the ₹9,375 crore market cap.
• Weak profitability: ROE of 4.54%, ROCE of 6.88%, zero dividend yield, and PEG of 4.41.
• Transparency risks: promoter holding and debt/equity are not available, and FairStock Score is only 14/100.

AI Analysis

At first glance, National Standar is not a business I can understand or value. It has a market capitalisation of ₹9,375 crore, yet in the latest quarter it generated only ₹3 crore of sales and ₹3 crore of profit. That means the stock is trading at 225.81 times earnings and 33.26 times book value for a company whose book value is just ₹138.98 per share. The price, ₹4,622.60, is at the very top of its 52-week range. When I see a P/E like that, I need exceptional economics underneath. Instead I see ROE of 4.54% and ROCE of 6.88%—hardly the hallmark of a durable competitive advantage. Sales have collapsed by 79.80%. The 51.16% profit growth sounds impressive, but it is from a tiny base and the PEG ratio of 4.41 tells me the growth is already more than priced in. There is no dividend, no disclosed promoter holding, and debt-to-equity is not available. As Graham would say, the stock market is a voting machine in the short run and a weighing machine in the long run. Right now, the voting has been enthusiastic—the stock has risen from ₹1,030 to ₹4,622.60 within the same 52-week period. But the weighing machine based on earnings, book value, and return on equity suggests an enormously heavy price. The Piotroski F-score of 6/9 is a small positive, but it cannot offset a valuation that offers no margin of safety. FairStock's risk score of 14/100 is consistent with my own unease. This is not a compounder. It may be a cyclical real estate business at a moment of hope, but hope is not an investment strategy. I would rather watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer